TÜV SÜD To Launch Medical Device Testing Lab
TÜV SÜD has laid the foundation stone for a new
state-of-the-art facility for testing and certifying electrical and electronic
products and medical devices (active and non-active) to national and
international standards in Bengaluru. The new integrated office and lab facility
is scheduled for completion in early 2023.
The ground-breaking ceremony was held in the presence of
Niranjan Nadkarni, CEO, TÜV SÜD South Asia, South East Asia, Middle East &
Africa Region, and Ezhilan Neelan, Senior VP, Product Service, TÜV SÜD South
Asia and other South Asia Management Members.
With an investment of €15 million, spanning across three
acres and comprising 70,000 sq feet in Phase 1, the new integrated office and
laboratory are located in KIADB Hitech Defense and Aerospace Park, Devanahalli,
Bengaluru and will be the second lab facility in Bengaluru.
As a result of this investment, TÜV SÜD will be able to offer
a onestop testing and certification solution for most electrical and electronic
products & medical devices.
KTR Inaugurates 7 Companies In Medical
These companies are making a total investment of Rs 265 crore
and will generate jobs for around 1,300 people.
Hyderabad: Telangana Industries Minister KT Rama Rao on
Wednesday inaugurated seven companies - Promea Therapeutics, Huwel Life
Sciences, Akriti Oculoplasty, Arka Engineers, SVP Techno Engineers, Elvikon and
Rees Medilife at the Medical Devices Park, supposed to be India's largest
facility of its kind, near Hyderabad.
These firms have made a total investment of Rs 265 crore and
employment generation for around 1,300 people.
Speaking on the occasion, the Minister noted that since its
launch in 2017, the park has received an overwhelming response with about 50
companies setting up their manufacturing and R&D units with an overall
investment commitment of Rs 1,424 crore and around 7,000 direct jobs.
He said that just in a span of few years, it has become one
of the leading and most attractive R&D and manufacturing destinations for the
medical devices companies, despite the setbacks faced by the industry and
entrepreneurs during the unprecedented Covid period.
The State government recognised medical devices and
diagnostics sector as a high-potential, high growth sector, which presents
"The park also reinforces the government's commitment to
strengthen the State's manufacturing capabilities which going forward, will help
attract even greater investments in a broad range of medical device product
segments ranging from capital equipment, implantable devices, diagnostics, and
consumables. We aim to make this park as not just a global factory for the world
but a global medtech innovation ecosystem," he said.
KTR said key discoveries, ranging from the development of
engineered modified RNA technology, which enabled rapid development of effective
Covid-19 vaccines, to bioprosthetic implants to at-home genetic testing kits to
cardiac diagnostic tools to handheld ultrasound devices, mobile ventilators,
oxygen concentrators, PPEs and other medical supplies, have propelled growth and
investments in the sector.
He claimed that Medtronic's largest research and development
centre outside the US serves as a testimony to Hyderabad's growing prowess for
medtech research in India. The centre has already started making its impact by
making significant contributions to the development and testing for robotic
assisted surgery system and also in the development of simplified and remotely
deployable solution that can help physicians monitor the vital parameters of
their patients, no matter where they are, thus ensuring safety and minimising
clinician exposure, he said.